首页 | 本学科首页   官方微博 | 高级检索  
     


Salivary Duct Carcinoma: An Aggressive Salivary Gland Carcinoma with Morphologic Variants,Newly Identified Molecular Characteristics,and Emerging Treatment Modalities
Affiliation:1. The Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA;2. Cleveland Clinic Head and Neck Pathology, Mail Code L25, 9500 Euclid Avenue, Cleveland, OH 44195, USA;1. Department of Pathology, National Taiwan University Hospital, No 7, Chung-Shan South Road, Taipei 100, Taiwan;2. Graduate Institute of Pathology, National Taiwan University College of Medicine, Taipei, Taiwan;3. Department of Pathology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA;4. Department of Dentistry, National Taiwan University Hospital, No. 1, Changde Street, Zhongzheng District, Taipei City 100, Taiwan;5. Department of Dentistry, Graduate Institute of Clinical Dentistry, School of Dentistry, National Taiwan University, Taipei, Taiwan;1. Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA;2. Center for Skull Base and Pituitary Surgery, Department of Neurosurgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA;1. Center for Neuro-Oncology, Dana Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA;2. Department of Pathology, Brigham and Women''s Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA
Abstract:
Keywords:Salivary duct carcinoma  Apocrine  Androgen receptor  Salivary gland  Molecular
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号